The Cost of Adrenal Insufficiency in England—Analysis of NHS Hospital Episode Statistics (HES) Data
Authors' conclusion
AI admissions have increased since 2018/19. Bed-days and cost for AC episodes have also risen. Patients with concomitant AI were more likely to have longer stays and be re-admitted. Endocrinology follow-up appears surprisingly low despite published guidelines.
Study context
- Population
- Hospital spells with adrenal insufficiency (AI) codes at NHS hospitals in England, financial years 2018/19 to 2022/23spells
- Participants
- 57,125 / 12,640 / 79,965
- Exposure
- PAI vs AC vs UAI
- PAIn = 57,125
- ACn = 12,640
- UAIn = 79,965
- Outcome
- Admissions, LOS and costs
- Follow-up
- 2018/19 to 2022/23
Methodological detailsNational Hospital Episode Statistics (HES) data set, all admissions and outpatient appointments at NHS hospitals in England
- National Hospital Episode Statistics (HES) data set
- All admissions and outpatient appointments at NHS hospitals in England
Main finding
As reported in the abstract
Mean LOS for AC increased from 5.1 to 6.8 days
34%
Mean cost per hospital stay for AC rose since 2019/20, reaching £2959 per stay
25%
Observational data: associations, not effects.
Further findings
>1 non-elective readmission within 12 months
- Patients with >1 non-elective readmission
- 10%
Endocrinologist follow-up · within 26 weeks of admission
- Centres treating > 225 spells/year reviewed AI patients within 26 weeks
- 20-46%
- Reviewed with a main diagnosis of AC in 2022/23
- 46%
- Endocrinologist follow-up was lower than expected
Original publication
The Cost of Adrenal Insufficiency in England—Analysis of NHS HES Data. Clin Endocrinol (Oxf). Published 4 February 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →